Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynamic Pharmaceuticals Invesco ETF (NY: PJP )

80.56 +0.48 (+0.60%)
Streaming Delayed Price Updated: 11:51 AM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,559
Open 80.32
Bid (Size) 80.30 (1)
Ask (Size) 80.36 (1)
Prev. Close 80.08
Today's Range 80.00 - 80.56
52wk Range 67.75 - 83.31
Shares Outstanding 33,400
Dividend Yield 1.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,... 
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
A Look At Pharma ETFs Post Q1 Earnings
Pharma ETFs have delivered mixed performances over the past month. 
Via Talk Markets
Topics ETFs

Performance

YTD
+5.38%
+5.38%
1 Month
-0.66%
-0.66%
3 Month
+3.40%
+3.40%
6 Month
+4.76%
+4.76%
1 Year
+7.26%
+7.26%

More News

Read More
A Look At Pharma ETFs After Q4 Earnings
Via Talk Markets
Topics ETFs
Government-granted Patent Monopolies Are Not The Free Market
Via Talk Markets
Topics Intellectual Property
Exposures Intellectual Property
Time For Gilead Sciences-Heavy ETFs?
Via Talk Markets
Pharma ETFs in Focus Post Q2 Earnings
Via Talk Markets
Topics ETFs
Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.
Via The Motley Fool
Pharma ETFs Gain Post Q1 Earnings
Via Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
Via Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
Via Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Via Talk Markets
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval?
Via Talk Markets
Exposures COVID-19 Product Safety
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer
Via Talk Markets
Exposures COVID-19
3 Cheap Pharmaceutical Stocks to Grab Now
Via Talk Markets
Exposures COVID-19
Pharma ETFs in Focus Post Q1 Earnings
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.